A phase I/II study of ruxolitinib with frontline neoadjuvant and post-surgical therapy in patients with advanced epithelial ovarian, Fallopian tube, or primary peritoneal cancer Meeting Abstract
| Authors: | Landen, C. N.; Buckanovich, R. J.; Sill, M.; Mannel, R. S.; Walker, J. L.; Disilvestro, P.; Mathews, C. A.; Mutch, D. G.; Hernandez, M.; Martin, L. P.; Bishop, E.; Gill, S.; Gordinier, M. E.; Burger, R. A.; Aghajanian, C.; Liu, J. F.; Moore, K. N.; Bookman, M. A. |
| Abstract Title: | A phase I/II study of ruxolitinib with frontline neoadjuvant and post-surgical therapy in patients with advanced epithelial ovarian, Fallopian tube, or primary peritoneal cancer |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680301555 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.5501 |
| Notes: | Meeting Abstract: 5501 -- Meeting also held virtually -- Source: Wos |
